Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Northwest Biotherapeutics Company Profile (NASDAQ:NWBO)

Consensus Ratings for Northwest Biotherapeutics (NASDAQ:NWBO) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $10.70 (98.15% upside)

Analysts' Ratings History for Northwest Biotherapeutics (NASDAQ:NWBO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/1/2014ZacksReiterated RatingOutperform -> Outperform$12.00ViewTweet This Rating  Share This Rating on StockTwits
3/12/2014OppenheimerDowngradeOutperform -> Market Perform$5.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2014Summer StreetBoost Price TargetBuy$10.33 -> $15.10ViewTweet This Rating  Share This Rating on StockTwits
10/16/2013OppenheimerInitiated CoverageNeutral -> Outperform$5.00ViewTweet This Rating  Share This Rating on StockTwits
9/19/2013Summer StreetInitiated CoverageBuy$10.33ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/18/2012 forward)